Neurotech International has received positive feedback from the European Medicines Agency (EMA) on the company’s Orphan ...
Medicines account for more than 13 per cent – about €3.3 billion – of a health budget that is permanently under strain. That ...
Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...
Ireland’s medicines approval system is no longer fit for purpose, but is the government committed to renewing it fairly?
Patients should have faster access to newly developed drugs and medicines and the Government is prepared to adopt new ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Medicines Agency (EMA) has validated for parallel accelerated review the company’s ...
Gilead Sciences, Inc. has received conditional marketing authorization from the European Commission (EC) for Seladelpar for the treatment of primary biliary cholangitis (PBC) ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the treatment of primary biliary cholangitis ...
Gilead Sciences (GILD) said on Friday that the European Commission (EC) granted conditional marketing authorization for ...
A new survey has revealed the huge scale and mindboggling complexity of the task facing pharma in keeping medicines moving around Europe after Brexit. No-one knows if or when the EU27 and the UK ...